ReP USP - Resultado da busca

Artigo de periodico
The association of biochemical and genetic biomarkers in VEGF pathway with depression (2022)
Nunes, Fernanda Daniela Dornelas; Ferezin, Letícia Perticarrara; Pereira, Sherliane Carla ; Figaro-Drumond, Fernanda Viana; Pinheiro, Lucas Cezar ; Menezes, Itiana Castro; Baes, Cristiane Von Werne ; Coeli-Lacchini, Fernanda Borchers ; Tanus-Santos, José Eduardo ; Juruena, Mario Francisco; Lacchini, Riccardo
Source: Pharmaceutics. Unidades: EERP, FMRP
Subjects: DEPRESSÃO, COMPORTAMENTO DE RISCO, SUICIDAS, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NUNES, Fernanda Daniela Dornelas et al. The association of biochemical and genetic biomarkers in VEGF pathway with depression. Pharmaceutics, v. 14, n. 12, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14122757. Acesso em: 10 nov. 2024.
APA
Nunes, F. D. D., Ferezin, L. P., Pereira, S. C., Figaro-Drumond, F. V., Pinheiro, L. C., Menezes, I. C., et al. (2022). The association of biochemical and genetic biomarkers in VEGF pathway with depression. Pharmaceutics, 14( 12), 1-15. doi:10.3390/pharmaceutics14122757
NLM
Nunes FDD, Ferezin LP, Pereira SC, Figaro-Drumond FV, Pinheiro LC, Menezes IC, Baes CVW, Coeli-Lacchini FB, Tanus-Santos JE, Juruena MF, Lacchini R. The association of biochemical and genetic biomarkers in VEGF pathway with depression [Internet]. Pharmaceutics. 2022 ; 14( 12): 1-15.[citado 2024 nov. 10 ] Available from: https://doi.org/10.3390/pharmaceutics14122757
Vancouver
Nunes FDD, Ferezin LP, Pereira SC, Figaro-Drumond FV, Pinheiro LC, Menezes IC, Baes CVW, Coeli-Lacchini FB, Tanus-Santos JE, Juruena MF, Lacchini R. The association of biochemical and genetic biomarkers in VEGF pathway with depression [Internet]. Pharmaceutics. 2022 ; 14( 12): 1-15.[citado 2024 nov. 10 ] Available from: https://doi.org/10.3390/pharmaceutics14122757
Artigo de periodico
Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability (2021)
Oliveira-Paula, Gustavo Henrique; Coeli-Lacchini, Fernanda Borchers; Ferezin, Letícia Perticarrara; Ferreira, Graziele Cristina ; Pinheiro, Lucas Cezar ; Garcia, Waynice Neiva de Paula ; Garcia, Luis Vicente ; Tanus-Santos, José Eduardo ; Lacchini, Riccardo
Source: European Journal of Clinical Pharmacology. Unidades: FMRP, EERP, FCFRP
Subjects: MEDICAMENTO, POLIMORFISMO, ÓXIDO NÍTRICO, ANESTESIA, PRESSÃO SANGUÍNEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA-PAULA, Gustavo Henrique et al. Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability. European Journal of Clinical Pharmacology, v. 77, n. 6, p. 869-877, 2021Tradução . . Disponível em: https://doi.org/10.1007/s00228-020-03059-9. Acesso em: 10 nov. 2024.
APA
Oliveira-Paula, G. H., Coeli-Lacchini, F. B., Ferezin, L. P., Ferreira, G. C., Pinheiro, L. C., Garcia, W. N. de P., et al. (2021). Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability. European Journal of Clinical Pharmacology, 77( 6), 869-877. doi:10.1007/s00228-020-03059-9
NLM
Oliveira-Paula GH, Coeli-Lacchini FB, Ferezin LP, Ferreira GC, Pinheiro LC, Garcia WN de P, Garcia LV, Tanus-Santos JE, Lacchini R. Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability [Internet]. European Journal of Clinical Pharmacology. 2021 ; 77( 6): 869-877.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1007/s00228-020-03059-9
Vancouver
Oliveira-Paula GH, Coeli-Lacchini FB, Ferezin LP, Ferreira GC, Pinheiro LC, Garcia WN de P, Garcia LV, Tanus-Santos JE, Lacchini R. Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability [Internet]. European Journal of Clinical Pharmacology. 2021 ; 77( 6): 869-877.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1007/s00228-020-03059-9
Artigo de periodico
Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts (2020)
Figaro-Drumond, Fernanda Viana; Pereira, Sherliane Carla ; Menezes, Itiana Castro; Baes, Cristiane Von Werne ; Coeli-Lacchini, Fernanda Borchers ; Oliveira-Paula, Gustavo Henrique; Cleare, Anthony J.; Young, Allan H.; Tanus-Santos, José Eduardo ; Juruena, Mário Francisco Pereira; Lacchini, Riccardo
Source: Behavioural Brain Research. Unidades: EERP, FMRP
Subjects: ANTIDEPRESSIVOS, USOS TERAPÊUTICOS, ESTUDOS DE CASOS E CONTROLES, QUIMIOTERAPIA, PREDISPOSIÇÃO GENÉTICA PARA DOENÇA, SISTEMA HIPOTÁLAMO-HIPOFISÁRIO, POLIMORFISMO, TENTATIVA DE SUICÍDIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FIGARO-DRUMOND, Fernanda Viana et al. Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts. Behavioural Brain Research, v. 81, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2019.112343. Acesso em: 10 nov. 2024.
APA
Figaro-Drumond, F. V., Pereira, S. C., Menezes, I. C., Baes, C. V. W., Coeli-Lacchini, F. B., Oliveira-Paula, G. H., et al. (2020). Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts. Behavioural Brain Research, 81. doi:10.1016/j.bbr.2019.112343
NLM
Figaro-Drumond FV, Pereira SC, Menezes IC, Baes CVW, Coeli-Lacchini FB, Oliveira-Paula GH, Cleare AJ, Young AH, Tanus-Santos JE, Juruena MFP, Lacchini R. Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts [Internet]. Behavioural Brain Research. 2020 ; 81[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.bbr.2019.112343
Vancouver
Figaro-Drumond FV, Pereira SC, Menezes IC, Baes CVW, Coeli-Lacchini FB, Oliveira-Paula GH, Cleare AJ, Young AH, Tanus-Santos JE, Juruena MFP, Lacchini R. Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts [Internet]. Behavioural Brain Research. 2020 ; 81[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.bbr.2019.112343
Artigo de periodico
DDAH1 and DDAH2 polymorphisms associate with asymmetrical dimethylarginine plasma levels in erectile dysfunction patients but not in healthy controls (2019)
Brites-Anselmi, Guilhermo; Azevedo, Ana Maria Milanez; Miyazaki, Anderson Heiji Lima ; Pinheiro, Lucas Cezar ; Coeli-Lacchini, Fernanda Borchers; Andrade, Murilo Ferreira de; Molina, Carlos Augusto Fernandes ; Tucci Júnior, Silvio; Hirsch, Emilio; Tanus-Santos, José Eduardo ; Lacchini, Riccardo
Source: Nitric Oxide. Unidades: EERP, FMRP
Subjects: ÓXIDO NÍTRICO, DISFUNÇÃO ERÉTIL, POLIMORFISMO (GENÉTICA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRITES-ANSELMI, Guilhermo et al. DDAH1 and DDAH2 polymorphisms associate with asymmetrical dimethylarginine plasma levels in erectile dysfunction patients but not in healthy controls. Nitric Oxide, v. 92, n. 1, p. 11-17, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.niox.2019.08.001. Acesso em: 10 nov. 2024.
APA
Brites-Anselmi, G., Azevedo, A. M. M., Miyazaki, A. H. L., Pinheiro, L. C., Coeli-Lacchini, F. B., Andrade, M. F. de, et al. (2019). DDAH1 and DDAH2 polymorphisms associate with asymmetrical dimethylarginine plasma levels in erectile dysfunction patients but not in healthy controls. Nitric Oxide, 92( 1), 11-17. doi:10.1016/j.niox.2019.08.001
NLM
Brites-Anselmi G, Azevedo AMM, Miyazaki AHL, Pinheiro LC, Coeli-Lacchini FB, Andrade MF de, Molina CAF, Tucci Júnior S, Hirsch E, Tanus-Santos JE, Lacchini R. DDAH1 and DDAH2 polymorphisms associate with asymmetrical dimethylarginine plasma levels in erectile dysfunction patients but not in healthy controls [Internet]. Nitric Oxide. 2019 ; 92( 1): 11-17.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.niox.2019.08.001
Vancouver
Brites-Anselmi G, Azevedo AMM, Miyazaki AHL, Pinheiro LC, Coeli-Lacchini FB, Andrade MF de, Molina CAF, Tucci Júnior S, Hirsch E, Tanus-Santos JE, Lacchini R. DDAH1 and DDAH2 polymorphisms associate with asymmetrical dimethylarginine plasma levels in erectile dysfunction patients but not in healthy controls [Internet]. Nitric Oxide. 2019 ; 92( 1): 11-17.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.niox.2019.08.001
Artigo de periodico
Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia (2019)
Sandrim, Valéria Cristina ; Coeli-Lacchini, Fernanda Borchers ; Tanus-Santos, José Eduardo ; Lacchini, Riccardo ; Cavalli, Ricardo de Carvalho
Source: Hypertension in Pregnancy. Unidades: FMRP, EERP, FCFRP
Subjects: POLIMORFISMO, PRÉ-ECLÂMPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANDRIM, Valéria Cristina et al. Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia. Hypertension in Pregnancy, v. 38, n. 2, p. 73-77, 2019Tradução . . Disponível em: https://doi.org/10.1080/10641955.2019.1582664. Acesso em: 10 nov. 2024.
APA
Sandrim, V. C., Coeli-Lacchini, F. B., Tanus-Santos, J. E., Lacchini, R., & Cavalli, R. de C. (2019). Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia. Hypertension in Pregnancy, 38( 2), 73-77. doi:10.1080/10641955.2019.1582664
NLM
Sandrim VC, Coeli-Lacchini FB, Tanus-Santos JE, Lacchini R, Cavalli R de C. Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia [Internet]. Hypertension in Pregnancy. 2019 ; 38( 2): 73-77.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1080/10641955.2019.1582664
Vancouver
Sandrim VC, Coeli-Lacchini FB, Tanus-Santos JE, Lacchini R, Cavalli R de C. Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia [Internet]. Hypertension in Pregnancy. 2019 ; 38( 2): 73-77.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1080/10641955.2019.1582664
Artigo de periodico
Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: impact on erectile dysfunction therapy (2017)
Azevedo, Ana Maria Milanez; Brites-Anselmi, Guilhermo; Pinheiro, Lucas Cezar; Belo, Vanessa de Almeida; Coeli-Lacchini, Fernanda Borchers; Molina, Carlos Augusto Fernandes; Andrade, Murilo Ferreira de; Tucci Júnior, Silvio; Hirsch, Emilio; Tanus-Santos, José Eduardo; Lacchini, Riccardo
Source: Nitric Oxide. Unidades: FMRP, EERP
Subjects: ARGININA, BIOMARCADORES, DISFUNÇÃO ERÉTIL, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AZEVEDO, Ana Maria Milanez et al. Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: impact on erectile dysfunction therapy. Nitric Oxide, v. 71, p. 44-51, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.niox.2017.10.006. Acesso em: 10 nov. 2024.
APA
Azevedo, A. M. M., Brites-Anselmi, G., Pinheiro, L. C., Belo, V. de A., Coeli-Lacchini, F. B., Molina, C. A. F., et al. (2017). Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: impact on erectile dysfunction therapy. Nitric Oxide, 71, 44-51. doi:10.1016/j.niox.2017.10.006
NLM
Azevedo AMM, Brites-Anselmi G, Pinheiro LC, Belo V de A, Coeli-Lacchini FB, Molina CAF, Andrade MF de, Tucci Júnior S, Hirsch E, Tanus-Santos JE, Lacchini R. Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: impact on erectile dysfunction therapy [Internet]. Nitric Oxide. 2017 ; 71 44-51.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.niox.2017.10.006
Vancouver
Azevedo AMM, Brites-Anselmi G, Pinheiro LC, Belo V de A, Coeli-Lacchini FB, Molina CAF, Andrade MF de, Tucci Júnior S, Hirsch E, Tanus-Santos JE, Lacchini R. Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: impact on erectile dysfunction therapy [Internet]. Nitric Oxide. 2017 ; 71 44-51.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.niox.2017.10.006

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation